Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
Cardlytics Price Performance
CDLX Stock traded up $0.10 during mid-day trading on Tuesday, hitting $16.86. The company had a trading volume of 10,231 shares, compared to its average volume of 844,615. The company has a 50-day moving average price of $19.26 and a 200 day moving average price of $37.70. Cardlytics has a 12-month low of $11.95 and a 12-month high of $99.47. The company has a market capitalization of $554.53 million, a price-to-earnings ratio of -3.68 and a beta of 2.10. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 0.40.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. JPMorgan Chase & Co. reduced their price target on Cardlytics from $47.00 to $35.00 and set a "neutral" rating on the stock in a research note on Wednesday, June 29th. Needham & Company LLC cut their price objective on shares of Cardlytics from $24.00 to $19.00 and set a "buy" rating on the stock in a research report on Wednesday, August 3rd. Wells Fargo & Company decreased their target price on shares of Cardlytics from $15.00 to $14.00 and set an "equal weight" rating for the company in a report on Wednesday, August 3rd. Bank of America cut shares of Cardlytics from a "neutral" rating to an "underperform" rating and set a $14.00 price target on the stock. in a report on Tuesday, July 12th. Finally, Craig Hallum cut shares of Cardlytics from a "buy" rating to a "hold" rating and lowered their target price for the company from $50.00 to $20.00 in a research note on Tuesday, July 12th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $20.40.
Insider Activity at Cardlytics
In other Cardlytics news, Director Scott D. Grimes sold 9,257 shares of the stock in a transaction on Friday, August 5th. The stock was sold at an average price of $15.19, for a total value of $140,613.83. Following the sale, the director now owns 238,594 shares in the company, valued at $3,624,242.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Cardlytics news, Director Scott D. Grimes sold 9,257 shares of the company's stock in a transaction on Friday, August 5th. The stock was sold at an average price of $15.19, for a total transaction of $140,613.83. Following the completion of the sale, the director now owns 238,594 shares in the company, valued at $3,624,242.86. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Lynne Marie Laube sold 6,612 shares of the company's stock in a transaction on Friday, August 5th. The stock was sold at an average price of $15.19, for a total value of $100,436.28. Following the transaction, the chief executive officer now directly owns 306,271 shares in the company, valued at $4,652,256.49. The disclosure for this sale can be found here. In the last 90 days, insiders have purchased 10,000 shares of company stock worth $220,940 and have sold 18,458 shares worth $288,786. 3.70% of the stock is currently owned by insiders.